Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1-Reference-Cited by-同舟云学术

Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1

Published:2021-02-09 Issue:2 Volume:2 Page:285-290
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Hagiwara Shinya¹,Kusumoto Shigeru¹^ORCID,Ito Asahi¹,Masaki Ayako²,Shiraga Kazuhide¹,Tachita Takuto¹³,Hirade Kentaro¹,Oiwa Kana¹,Suzuki Tomotaka¹,Kinoshita Shiori¹,Ri Masaki¹,Ito Yasuhiko⁴⁵,Komatsu Hirokazu¹,Inagaki Hiroshi²,Iida Shinsuke¹

Affiliation:

1. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

2. Department of Pathology and Molecular Diagnostics Nagoya City University Graduate School of Medical Sciences Nagoya Japan

3. Department of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Hirosaki Japan

4. Department of Pediatrics and Neonatology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

5. Nagoya City West Medical Center Pediatrics Nagoya Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.169

Reference15 articles.

1. LEUKÆMIC TRANSFORMATION OF ENGRAFTED HUMAN MARROW CELLS IN VIVO

2. Donor Cell Leukemia: A Review

3. Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

4. Donor Cell–Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review

5. European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene‐CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT);British Journal of Haematology;2023-02-14